Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018, Article ID 7971842, 10 pages
Research Article

Galangin and Pinocembrin from Propolis Ameliorate Insulin Resistance in HepG2 Cells via Regulating Akt/mTOR Signaling

1Institute of Apicultural Research, Chinese Academy of Agricultural Sciences, Beijing 100093, China
2College of Food Engineering, Harbin University of Commerce, Harbin 150076, China
3National Research Center of Bee Product Processing, Ministry of Agriculture, Beijing 100093, China

Correspondence should be addressed to Wenjun Peng; moc.anis.piv@nujnewgnep and Hongcheng Zhang; moc.qq@478414064

Received 10 July 2018; Accepted 16 October 2018; Published 21 October 2018

Academic Editor: Nunziatina De Tommasi

Copyright © 2018 Yinkang Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [2 citations]

The following is the list of published articles that have cited the current article.

  • Xiaoling Shen, Yeju Liu, Xiaoya Luo, and Zhihong Yang, “Advances in Biosynthesis, Pharmacology, and Pharmacokinetics of Pinocembrin, a Promising Natural Small-Molecule Drug,” Molecules, vol. 24, no. 12, pp. 2323, 2019. View at Publisher · View at Google Scholar
  • Fatemeh Afsharpour, Maryam Javadi, Sima Hashemipour, Yaghob Koushan, and Hossein Khadem haghighian, “Propolis supplementation improves glycemic and antioxidant status in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study,” Complementary Therapies in Medicine, 2019. View at Publisher · View at Google Scholar